Scott Gleason | Senior Vice President of Investor Relations and Corporate Strategy |
Paul Diaz | President and Chief Executive Officer |
Bryan Riggsbee | Chief Financial Officer |
Doug Schenkel | Cowen |
Steve Unger | Needham |
Tycho Peterson | JPMorgan |
Puneet Souda | SVB Leerink |
Derik de Bruin | Bank of America |
Jack Meehan | Nephron |
Greetings and welcome to the Myriad Genetics First Quarter 2021 Financial Earnings Call.
During the presentation, all participants will be in a listen-only mode. Afterwards, we will conduct a question-and-answer session. [Operator Instructions] And as a remainder, this call is being recorded today, Monday, November 9, 2020. I would now like to turn the conference over to Scott Gleason, VP, Investor Relations.